Thomas Campbell, MD

Morales AE, Gumenick R, Genovese CM, Jang YY, Ouedraogo A, Ibáñez de Garayo M, Pannellini T, Patel S, Bott ME, Alvarez J, Mun SS, Totonchy J, Gautam A, Delgado de la Mora J, Chang S, Wirth D, Horenstein M, Dao T, Scheinberg DA, Rubinstein PG, Semeere A, Martin J, Godfrey CC, Moser CB, Matining RM, Campbell TB, Borok MZ, Krown SE, Cesarman E. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP. PLoS Pathog. 2024 Jan;20(1):e1011881. PubMed PMID: 38190392

Lazzaro A, Colorado ASB, Neff CP, Nusbacher N, Boyd K, Fiorillo S, Martin C, Siebert J, Campbell T, Borok M, Palmer B, Lozupone C. Antiretroviral treatment is less effective at reducing gut microbiome-associated inflammation and T cell activation in people living with HIV in rural versus urban Zimbabwe. Res Sq. 2023 Aug 31. PubMed PMID: 37693491

Epeldegui M, Chang D, Lee J, Magpantay LI, Borok M, Bukuru A, Busakhala N, Godfrey C, Hosseinipour MC, Kang M, Kanyama C, Langat D, Mngqibisa R, Mwelase N, Nyirenda M, Samaneka W, Hoagland B, Campbell TB, Martínez-Maza O, Krown SE. Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2023 Oct 1;94(2):165-173. PubMed PMID: 37368929

Letendre SL, Chen H, McKhann A, Roa J, Vecchio A, Daar ES, Berzins B, Hunt PW, Marra CM, Campbell TB, Coombs RW, Ma Q, Swaminathan S, Macatangay BJC, Morse GD, Miller T, Rusin D, Greninger AL, Ha B, Alston-Smith B, Robertson K, Paul R, Spudich S. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus. Clin Infect Dis. 2023 Sep 18;77(6):866-874. PubMed PMID: 37183889

Altman NL, Berning AA, Mann SC, Quaife RA, Gill EA, Auerbach SR, Campbell TB, Bristow MR. Vaccination-Associated Myocarditis and Myocardial Injury. Circ Res. 2023 May 12;132(10):1338-1357. PubMed PMID: 37167355

Zanni MV, Foldyna B, McCallum S, Burdo TH, Looby SE, Fitch KV, Fulda ES, Autissier P, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Overton ET, Aberg JA, Erlandson KM, Campbell TB, Ellsworth GB, Sheth AN, Taiwo B, Currier JS, Hoffmann U, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon SK. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2023 Jan 13;76(2):323-334. PubMed PMID: 36101518

Nyangwara VA, Mazhindu T, Chikwambi Z, Masimirembwa C, Campbell TB, Borok M, Ndlovu N. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. Br J Clin Pharmacol. 2023 Jan 11. [Epub ahead of print] PubMed PMID: 36630266

Mazhindu T, Ndlovu N, Borok MZ, Meki S, Nyamhunga A, Havranek EP, Kessler ER, Campbell TB, Flaig TW. Metabolic and cardiovascular disease risk for Zimbabwean men with prostate cancer receiving long-term androgen deprivation therapy. Res Sq. 2023 Dec 12. PubMed PMID: 38168443

Huang Y, Hejazi NS, Blette B, Carpp LN, Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Kenny A, Carone M, Huynh C, Miller J, El Sahly HM, Baden LR, Jackson LA, Campbell TB, Clark J, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Pajon R, Follmann D, Donis RO, Koup RA, Gilbert PB, On Behalf Of The Immune Assays, Moderna Inc, Coronavirus Vaccine Prevention Network CoVPN/Coronavirus Efficacy Cove, United States Government Usg/CoVPN Biostatistics Teams. Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial. Viruses. 2023 Sep 29;15(10). PubMed PMID: 37896806

Nyangwara VA, Mazhindu T, Chikwambi Z, Masimirembwa C, Campbell TB, Borok M, Ndlovu N. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. Br J Clin Pharmacol. 2023 Jan 11. [Epub ahead of print] PubMed PMID: 36630266

Altman NL, Berning AA, Saxon CE, Adamek KE, Wagner JA, Slavov D, Quaife RA, Gill EA, Minobe WA, Jonas ER, Carroll IA, Huebler SP, Raines J, Messenger JC, Ambardekar AV, Mestroni L, Rosenberg RM, Rove J, Campbell TB, Bristow MR. Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA Vaccination. JACC Basic Transl Sci. 2022 Oct 19. [Epub ahead of print] PubMed PMID: 36281440

Sabourin KR, Borok M, Mawhinney S, Matimba M, Jaji F, Fiorillo S, Chifamba DD, Muserere C, Mashiri B, Bhodheni C, Gambiza P, Mandidewa R, Mutimuri M, Gudza I, Mulvahill M, Moore CM, Kutner JS, Simões EAF, Campbell TB. Evaluation of a training intervention to improve cancer care in Zimbabwe: Strategies to Improve Kaposi Sarcoma Outcomes (SIKO), a prospective community-based stepped-wedge cluster randomized trial. J Int AIDS Soc. 2022 Aug;25(8):e25998. PubMed PMID: 36028920

Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, Campbell TB, Falta MT, Jolley SE, Fontenot AP, Palmer BE. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022 May;18(5):e1010359. PubMed PMID: 35617421

Yamada E, Martin CG, Moreno-Huizar N, Fouquier J, Neff CP, Coleman SL, Schneider JM, Huber J, Nusbacher NM, McCarter M, Campbell TB, Lozupone CA, Palmer BE. Intestinal microbial communities and Holdemanella isolated from HIV /- men who have sex with men increase frequencies of lamina propria CCR5( ) CD4( ) T cells. Gut Microbes. 2021 Jan-Dec;13(1):1997292. PubMed PMID: 34818131

El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 4;385(19):1774-1785. PubMed PMID: 34551225

Campbell T, Kassaye S, Winslow DL. David Katzenstein and James Hakim-In Memoriam. AIDS. 2021 Jul 1;35(8):1331-1332. PubMed PMID: 34076621

Armstrong AJS, Quinn K, Fouquier J, Li SX, Schneider JM, Nusbacher NM, Doenges KA, Fiorillo S, Marden TJ, Higgins J, Reisdorph N, Campbell TB, Palmer BE, Lozupone CA. Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations. mSystems. 2021 May 18;6(3). PubMed PMID: 34006628

Erlandson KM, Wilson MP, MaWhinney S, Rapaport E, Liu J, Wilson CC, Rahkola JT, Janoff EN, Brown TT, Campbell TB, Jankowski CM. The Impact of Moderate or High-Intensity Combined Exercise on Systemic Inflammation Among Older Persons With and Without HIV. J Infect Dis. 2021 Apr 8;223(7):1161-1170. PubMed PMID: 32779711

Matiza T, Boyd KF, Lyall RA, Kwon DS, McGregor AM, Fiorillo S, Campbell TB, Borok M, Corleis B. Compartmentalized T cell profile in the lungs of patients with HIV-1-associated pulmonary Kaposi sarcoma. Medicine (Baltimore). 2021 Dec 23;100(51):e28328. PubMed PMID: 34941134

Neff CP, Atif SM, Logue EC, Siebert J, Görg C, Lavelle J, Fiorillo S, Twigg H, Campbell TB, Fontenot AP, Palmer BE. HIV Infection Is Associated with Loss of Anti-Inflammatory Alveolar Macrophages. J Immunol. 2020 Nov 1;205(9):2447-2455. PubMed PMID: 32929038

Erlandson KM, Wilson MP, MaWhinney S, Rapaport E, Liu J, Wilson CC, Rahkola JT, Janoff EN, Brown TT, Campbell TB, Jankowski CM. The Impact of Moderate or High-Intensity Combined Exercise on Systemic Inflammation among Older Persons with and without HIV. J Infect Dis. 2020 Aug 11. [Epub ahead of print] PubMed PMID: 32779711

Jankowski CM, Mawhinney S, Wilson MP, Campbell TB, Kohrt WM, Schwartz RS, Brown TT, Erlandson KM. Body Composition Changes in Response to Moderate- or High-Intensity Exercise Among Older Adults With or Without HIV Infection. J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):340-345. PubMed PMID: 32701826

Nyirenda M, Ngongondo M, Kang M, Umbleja T, Krown SE, Godfrey C, Samaneka W, Mngqibisa R, Hoagland B, Mwelase N, Caruso S, Martinez-Maza O, Dittmer DP, Borok M, Hosseinipour MC, Campbell TB. Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy. J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):422-429. PubMed PMID: 32265361

Armstrong AJS, Shaffer M, Nusbacher NM, Griesmer C, Fiorillo S, Schneider JM, Neff CP, Li SX, Fontenot AP, Campbell T, Palmer BE, Lozupone CA. Correction to: An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome. 2020 Apr 6;8(1):50. PubMed PMID: 32252810

Krown SE, Moser CB, MacPhail P, Matining RM, Godfrey C, Caruso SR, Hosseinipour MC, Samaneka W, Nyirenda M, Busakhala NW, Okuku FM, Kosgei J, Hoagland B, Mwelase N, Oliver VO, Burger H, Mngqibisa R, Nokta M, Campbell TB, Borok MZ. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet. 2020 Apr 11;395(10231):1195-1207. PubMed PMID: 32145827

Coleman SL, Neff CP, Li SX, Armstrong AJS, Schneider JM, Sen S, Fennimore B, Campbell TB, Lozupone CA, Palmer BE. Can gut microbiota of men who have sex with men influence HIV transmission?. Gut Microbes. 2020 May 3;11(3):610-619. PubMed PMID: 32036739

Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N, Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firnhaber C, Hosseinipour MC, Mngqibisa R, Hall C, Cinque P, Robertson K. Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings. Clin Infect Dis. 2020 Jun 24;71(1):158-165. PubMed PMID: 31630166

Logue EC, Neff CP, Mack DG, Martin AK, Fiorillo S, Lavelle J, Vandivier RW, Campbell TB, Palmer BE, Fontenot AP. Upregulation of Chitinase 1 in Alveolar Macrophages of HIV-Infected Smokers. J Immunol. 2019 Jan 21. [Epub ahead of print] PubMed PMID: 30665939

Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N, Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firnhaber C, Hosseinipour MC, Mngqibisa R, Hall C, Cinque P, Robertson K. Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings. Clin Infect Dis. 2019 Aug 12. [Epub ahead of print] PubMed PMID: 31630166

Li SX, Sen S, Schneider JM, Xiong KN, Nusbacher NM, Moreno-Huizar N, Shaffer M, Armstrong AJS, Severs E, Kuhn K, Neff CP, McCarter M, Campbell T, Lozupone CA, Palmer BE. Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection. PLoS Pathog. 2019 Apr;15(4):e1007611. PubMed PMID: 30947289

Nir TM, Jahanshad N, Ching CRK, Cohen RA, Harezlak J, Schifitto G, Lam HY, Hua X, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Singer EJ, Alger JR, Thompson PM, Navia BA. Progressive brain atrophy in chronically infected and treated HIV individuals. J Neurovirol. 2019 Jun;25(3):342-353. PubMed PMID: 30767174

Logue EC, Neff CP, Mack DG, Martin AK, Fiorillo S, Lavelle J, Vandivier RW, Campbell TB, Palmer BE, Fontenot AP. Upregulation of Chitinase 1 in Alveolar Macrophages of HIV-Infected Smokers. J Immunol. 2019 Mar 1;202(5):1363-1372. PubMed PMID: 30665939

Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firhnhaber C, Murphy R, Hall C, Marcus C, Naini L, Masih R, Hosseinipour MC, Mngqibisa R, Badal-Faesen S, Yosief S, Vecchio A, Nair A. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings. Clin Infect Dis. 2019 May 2;68(10):1733-1738. PubMed PMID: 30219843

Robertson KR, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell TB, Hakim J, Tripathy S, Hosseinipour MC, Marra CM, Kumarasamy N, Evans S, Vecchio A, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Firnhaber C, Price R, Marcus C, Berzins B, Masih R, Lalloo U, Sanne I, Yosief S, Walawander A, Nair A, Sacktor N, Hall C. Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction. Clin Infect Dis. 2019 May 2;68(10):1739-1746. PubMed PMID: 30137250

Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A. Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr. 2019 Jun;38(3):1303-1309. PubMed PMID: 29885777

Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin J, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok-Williams M, Samaneka W, Moses A, Mngqbisa R, Busakhala N, Martínez-Maza O, Ambinder R, Dittmer DP, Nokta M, Campbell TB. As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis. 2018 Jan 22. [Epub ahead of print] PubMed PMID: 29365083

Armstrong AJS, Shaffer M, Nusbacher NM, Griesmer C, Fiorillo S, Schneider JM, Preston Neff C, Li SX, Fontenot AP, Campbell T, Palmer BE, Lozupone CA. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome. 2018 Nov 5;6(1):198. PubMed PMID: 30396369

Shivakoti R, Gupte N, Tripathy S, Poongulali S, Kanyama C, Berendes S, Cardoso SW, Santos BR, La Rosa A, Mwelase N, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Bollinger RC, Balagopal A, Semba RD, Christian P, Campbell TB, Gupta A. Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study. BMC Med. 2018 Sep 24;16(1):161. PubMed PMID: 30244671

Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firhnhaber C, Murphy R, Hall C, Marcus C, Naini L, Masih R, Hosseinipour MC, Mngqibisa R, Badal-Faesen S, Yosief S, Vecchio A, Nair A. HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings. Clin Infect Dis. 2018 Sep 13. [Epub ahead of print] PubMed PMID: 30219843

Robertson K, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell T, Hakim J, Tripathy S, Hosseinipour M, Marra CM, Kumarasamy N, Evans S, Vecchio A, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Firnhaber C, Price R, Marcus C, Berzins B, Masih R, Lalloo U, Sanne I, Yosief S, Walawander A, Nair A, Sacktor N, Hall C. HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction. Clin Infect Dis. 2018 Aug 20. [Epub ahead of print] PubMed PMID: 30137250

Erlandson KM, MaWhinney S, Wilson M, Gross L, McCandless SA, Campbell TB, Kohrt WM, Schwartz R, Brown TT, Jankowski CM. Physical function improvements with moderate or high-intensity exercise among older adults with or without HIV infection. AIDS. 2018 Oct 23;32(16):2317-2326. PubMed PMID: 30134299

Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, Michael NL, Peter L, Nkolola JP, Borducchi EN, Chandrashekar A, Jetton D, Stephenson KE, Li W, Korber B, Tomaras GD, Montefiori DC, Gray G, Frahm N, McElrath MJ, Baden L, Johnson J, Hutter J, Swann E, Karita E, Kibuuka H, Mpendo J, Garrett N, Mngadi K, Chinyenze K, Priddy F, Lazarus E, Laher F, Nitayapan S, Pitisuttithum P, Bart S, Campbell T, Feldman R, Lucksinger G, Borremans C, Callewaert K, Roten R, Sadoff J, Scheppler L, Weijtens M, Feddes-de Boer K, van Manen D, Vreugdenhil J, Zahn R, Lavreys L, Nijs S, Tolboom J, Hendriks J, Euler Z, Pau MG, Schuitemaker H. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Lancet. 2018 Jul 21;392(10143):232-243. PubMed PMID: 30047376

Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F, Cu-Uvin S, Wu X, Currier JS. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy. PLoS One. 2018;13(7):e0199555. PubMed PMID: 30020964

Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A. Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr. 2018 May 29. [Epub ahead of print] PubMed PMID: 29885777

Neff CP, Krueger O, Xiong K, Arif S, Nusbacher N, Schneider JM, Cunningham AW, Armstrong A, Li S, McCarter MD, Campbell TB, Lozupone CA, Palmer BE. Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals. EBioMedicine. 2018 Apr;30:192-202. PubMed PMID: 29650491

Hakim JG, Chidzonga MM, Borok MZ, Nathoo KJ, Matenga J, Havranek E, Cowan F, Abas M, Aagaard E, Connors S, Nkomani S, Ndhlovu CE, Matsika A, Barry M, Campbell TB. Medical Education Partnership Initiative (MEPI) in Zimbabwe: Outcomes and Challenges. Glob Health Sci Pract. 2018 Mar 21;6(1):82-92. PubMed PMID: 29602867

Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin JN, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok M, Samaneka W, Moses A, Mngqbisa R, Busakhala N, Martínez-Maza O, Ambinder R, Dittmer DP, Nokta M, Campbell TB. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis. 2018 Jul 2;67(2):251-260. PubMed PMID: 29365083

Hakim JG, Barry M, Matenga J, Cowan F, Campbell TB. Medical Education Partnership Initiative in Zimbabwe: partnerships for transformation. Lancet Glob Health. 2017 Feb;5(2):e143-e144. PubMed PMID: 28104181

Erlandson KM, Kitch D, Wester CW, Kalayjian RC, Overton ET, Castillo-Mancilla J, Koletar SL, Benson CA, Campbell TB, Robertson K, Lok JJ. The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 Nov 29;65(12):2042-2049. PubMed PMID: 29020174

Mollan KR, Tierney C, Hellwege JN, Eron JJ, Hudgens MG, Gulick RM, Haubrich R, Sax PE, Campbell TB, Daar ES, Robertson KR, Ventura D, Ma Q, Edwards DRV, Haas DW. Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants. J Infect Dis. 2017 Sep 1;216(5):554-564. PubMed PMID: 28931220

Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, Hakim J, Kumarasamy N, Campbell TB. Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis. 2017 Mar 15;215(6):907-910. PubMed PMID: 28453835

Erlandson KM, Fiorillo SP, Cardoso SW, Riviere C, Sanchez J, Hakim J, Kumarasamy N, Badal-Faesen S, Lalloo U, Kumwenda J, Campbell TB, Brown TT. Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation. AIDS Res Hum Retroviruses. 2017 Sep;33(9):929-934. PubMed PMID: 28403619

Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Christian P, Semba RD, Campbell TB, Gupta A. Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study. J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):e71-e79. PubMed PMID: 28169875

Hakim JG, Barry M, Matenga J, Cowan F, Campbell TB. Medical Education Partnership Initiative in Zimbabwe: partnerships for transformation. Lancet Glob Health. 2017 Feb;5(2):e143-e144. PubMed PMID: 28104181

Logan C, Todorof K, Fiorillo SP, Campbell TB, Elder JH, Borok M, Gudza I, Gwanzura L, Ndemera B, Lochhead MJ, Benson CA, Schooley RT. Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. PLoS One. 2016 Sep 26;11(9):e0163616. PubMed PMID: 27669509

Singini I, Campbell TB, Smeaton LM, Kumarasamy N, La Rosa A, Taejareonkul S, Safren SA, Flanigan TP, Hakim JG, Hughes MD. Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy. HIV Clin Trials. 2016 Jul 29;:1-8. [Epub ahead of print] PubMed PMID: 27472067

Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):123-9. PubMed PMID: 27258230

Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, Smeaton L, Kumarasamy N, Hakim J, Santos B, Riviere C, Hosseinipour MC, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Tripathy S, Mwelase N, Berendes S, Andrade BB, Thomas DL, Bollinger RC, Gupta A. Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults. J Infect Dis. 2016 Jul 1;214(1):65-72. PubMed PMID: 26962236

Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kumarasamy N, Andrade A, Baheti G, Fletcher CV, Campbell TB, Haas DW, MaWhinney S, Anderson PL. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 Jun;71(6):1609-18. PubMed PMID: 26892777

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A. International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neurovirol. 2016 Aug;22(4):472-8. PubMed PMID: 26733457

Shivakoti R, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Balagopal A, Gupte N, Semba RD, Campbell TB, Bollinger RC, Gupta A. Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings. J Infect Dis. 2016 Apr 1;213(7):1074-8. PubMed PMID: 26621909

Shivakoti R, Christian P, Yang WT, Gupte N, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Tang AM, Semba RD, Campbell TB, Gupta A. Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults. Clin Nutr. 2016 Feb;35(1):183-9. PubMed PMID: 25703452

Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kumarasamy N, Andrade A, Baheti G, Fletcher CV, Campbell TB, Haas DW, MaWhinney S, Anderson PL. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 Feb 17. [Epub ahead of print] PubMed PMID: 26892777

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A. International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neurovirol. 2016 Jan 5. [Epub ahead of print] PubMed PMID: 26733457

Shivakoti R, Christian P, Yang WT, Gupte N, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Tang AM, Semba RD, Campbell TB, Gupta A. Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults. Clin Nutr. 2016 Feb;35(1):183-9. PubMed PMID: 25703452

Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, Kumwenda J, La Rosa A, Lalloo UG, Lama JR, Rassool M, Santos BR, Supparatpinyo K, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, Eshleman SH. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial. Clin Infect Dis. 2015 May 15;60(10):1541-9. PubMed PMID: 25681380

Allshouse AA, MaWhinney S, Jankowski CM, Kohrt WM, Campbell TB, Erlandson KM. The Impact of Marijuana Use on the Successful Aging of HIV-Infected Adults. J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):187-92. PubMed PMID: 25647530

Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, Singer EJ, Campbell TB, McMahon DD, Buchthal S, Cohen R, Yiannoutsos C, Letendre SL, Navia BA. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015 May 1;69(1):29-35. PubMed PMID: 25622053

Erlandson KM, Campbell TB. Inflammation in Chronic HIV Infection: What Can We Do?. J Infect Dis. 2015 Aug 1;212(3):339-42. PubMed PMID: 25583171

Neff CP, Chain JL, MaWhinney S, Martin AK, Linderman DJ, Flores SC, Campbell TB, Palmer BE, Fontenot AP. Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects. Am J Respir Crit Care Med. 2015 Feb 15;191(4):464-73. PubMed PMID: 25536276

Mould-Millman NK, Rominski SD, Bogus J, Ginde AA, Zakariah AN, Boatemaah CA, Yancey AH, Akoriyea SK, Campbell TB. Barriers to Accessing Emergency Medical Services in Accra, Ghana: Development of a Survey Instrument and Initial Application in Ghana. Glob Health Sci Pract. 2015 Dec;3(4):577-90. PubMed PMID: 26681705

Shivakoti R, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Balagopal A, Gupte N, Semba RD, Campbell TB, Bollinger RC, Gupta A. Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings. J Infect Dis. 2015 Nov 29. [Epub ahead of print] PubMed PMID: 26621909

Beck JM, Schloss PD, Venkataraman A, Twigg H 3rd, Jablonski KA, Bushman FD, Campbell TB, Charlson ES, Collman RG, Crothers K, Curtis JL, Drews KL, Flores SC, Fontenot AP, Foulkes MA, Frank I, Ghedin E, Huang L, Lynch SV, Morris A, Palmer BE, Schmidt TM, Sodergren E, Weinstock GM, Young VB. Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1335-44. PubMed PMID: 26247840

Erlandson KM, Taejaroenkul S, Smeaton L, Gupta A, Singini IL, Lama JR, Mngqibisa R, Firnhaber C, Cardoso SW, Kanyama C, Machado da Silva AL, Hakim JG, Kumarasamy N, Campbell TB, Hughes MD. A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings. Open Forum Infect Dis. 2015 Sep;2(3):ofv095. PubMed PMID: 26213694

Erlandson KM, Allshouse AA, Rapaport E, Palmer BE, Wilson CC, Weinberg A, MaWhinney S, Campbell TB. Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response. AIDS Res Hum Retroviruses. 2015 Sep;31(9):905-12. PubMed PMID: 26061347

Orlov M, Smeaton LM, Kumwenda J, Hosseinipour MC, Campbell TB, Schooley RT. Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. PLoS One. 2015;10(6):e0129519. PubMed PMID: 26053030

Labo N, Miley W, Benson CA, Campbell TB, Whitby D. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy. AIDS. 2015 Jun 19;29(10):1217-25. PubMed PMID: 26035321

Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS. 2015 Jun 19;29(10):1173-82. PubMed PMID: 26035319

Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A. Pre-cART Elevation of CRP and CD4 T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study. J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):163-71. PubMed PMID: 26017661

Firnhaber C, Smeaton LM, Grinsztejn B, Lalloo U, Faesen S, Samaneka W, Infante R, Rana A, Kumarasamy N, Hakim J, Campbell TB. Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial. HIV Clin Trials. 2015 May-Jun;16(3):89-99. PubMed PMID: 25979186

Erlandson KM, O'Riordan M, Hileman CO, Rapaport E, Labbato D, Campbell TB, McComsey GA. Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2015 Jul;31(7):731-8. PubMed PMID: 25919636

Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation. Clin Infect Dis. 2015 Jul 1;61(1):102-10. PubMed PMID: 25828994

Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One. 2015;10(2):e0117424. PubMed PMID: 25719208

Neff CP, Chain JL, MaWhinney S, Martin AK, Linderman DJ, Flores SC, Campbell TB, Palmer BE, Fontenot AP. Lymphocytic Alveolitis is Associated with the Accumulation of Functionally Impaired HIV-specific T Cells in the Lung of ART-naive Subjects. Am J Respir Crit Care Med. 2014 Dec 23. [Epub ahead of print] PubMed PMID: 25536276

Touzard Romo F, Smeaton LM, Campbell TB, Riviere C, Mngqibisa R, Nyirenda M, Supparatpinyo K, Kumarasamy N, Hakim JG, Flanigan TP. Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175). HIV Clin Trials. 2014 Nov-Dec;15(6):246-60. PubMed PMID: 25433664

Shivakoti R, Gupte N, Yang WT, Mwelase N, Kanyama C, Tang AM, Pillay S, Samaneka W, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Christian P, Campbell TB, Gupta A, NWCS 319 and PEARLS study team. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy. Nutrients. 2014 Nov 13;6(11):5061-78. PubMed PMID: 25401501

Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB, PEARLS (ACTG A5175) Study Team. Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS One. 2014;9(8):e104178. PubMed PMID: 25153084

Lozupone CA, Rhodes ME, Neff CP, Fontenot AP, Campbell TB, Palmer BE. HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy. Gut Microbes. 2014 Jul 1;5(4):562-70. PubMed PMID: 25078714

Krown SE, Borok MZ, Campbell TB, Casper C, Dittmer DP, Hosseinipour MC, Mitsuyasu RT, Mosam A, Orem J, Phipps WT. Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments. J Clin Oncol. 2014 Aug 10;32(23):2512-3. PubMed PMID: 25002726

Erlandson KM, Allshouse AA, Jankowski CM, Mawhinney S, Kohrt WM, Campbell TB. Relationship of physical function and quality of life among persons aging with HIV infection. AIDS. 2014 Aug 24;28(13):1939-43. PubMed PMID: 24992000

Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med. 2014 Jul 1;161(1):1-10. PubMed PMID: 24979445

Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep. 2014 Sep;11(3):279-90. PubMed PMID: 24966138

Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15;59(6):888-96. PubMed PMID: 24842909

Steele AK, Lee EJ, Vestal B, Hecht D, Dong Z, Rapaport E, Koeppe J, Campbell TB, Wilson CC. Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signature. PLoS One. 2014;9(5):e97171. PubMed PMID: 24819230

Havers F, Smeaton L, Gupte N, Detrick B, Bollinger RC, Hakim J, Kumarasamy N, Andrade A, Christian P, Lama JR, Campbell TB, Gupta A, ACTG PEARLS, NWCS 319 Study Teams. 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings. J Infect Dis. 2014 Jul 15;210(2):244-53. PubMed PMID: 24799602

Erlandson KM, Gudza I, Fiorillo S, Ndemera B, Schooley RT, Gwanzura L, Borok M, Campbell TB. Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe. Int J Infect Dis. 2014 Jul;24:6-10. PubMed PMID: 24769175

Havers FP, Detrick B, Cardoso SW, Berendes S, Lama JR, Sugandhavesa P, Mwelase NH, Campbell TB, Gupta A, ACTG A5175 PEARLS and NWCS319 Study Teams. Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings. PLoS One. 2014;9(4):e95164. PubMed PMID: 24752177

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, Navia BA, HIV Neuroimaging Consortium. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. J Neurovirol. 2014 Jun;20(3):294-303. PubMed PMID: 24696364

Gray J, Fana GT, Campbell TB, Hakim JG, Borok MZ, Aagaard EM. Feasibility and sustainability of an interactive team-based learning method for medical education during a severe faculty shortage in Zimbabwe. BMC Med Educ. 2014 Mar 28;14:63. PubMed PMID: 24678606

Yogo N, Nichol AC, Campbell TB, Erlandson KM. Syphilis presenting as retinal detachment and orchitis in a young man with HIV. Sex Transm Dis. 2014 Feb;41(2):114-6. PubMed PMID: 24413491

Gersh JK, Fiorillo SP, Burghardt L, Nichol AC, Thrun M, Campbell TB. Attitudes and Barriers towards Pre-Exposure Prophylaxis (Prep) among High- Risk HIV-Seronegative Men who have Sex with Men. J AIDS Clin Res 2014;5:335.

Ndhlovu CE, Nathoo K, Borok M, Chidzonga M, Aagaard EM, Connors SC, Barry M, Campbell T, Hakim J. Innovations to enhance the quality of health professions education at the University of Zimbabwe College of Health Sciences--NECTAR program. Acad Med. 2014 Aug;89(8 Suppl):S88-92. PubMed PMID: 25072588

Yogo N, Nichol AC, Campbell TB, Erlandson KM. Syphilis presenting as retinal detachment and orchitis in a young man with HIV. Sex Transm Dis. 2014 Feb;41(2):114-6. PubMed PMID: 24413491

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, Navia BA, The HIV Neuroimaging Consortium. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. J Neurovirol. 2014 Apr 3. [Epub ahead of print] PubMed PMID: 24696364

Gray J, Fana GT, Campbell TB, Hakim JG, Borok MZ, Aagaard EM. Feasibility and sustainability of an interactive team-based learning method for medical education during a severe faculty shortage in Zimbabwe. BMC Med Educ. 2014 Mar 28;14:63. PubMed PMID: 24678606

Twigg HL 3rd, Morris A, Ghedin E, Curtis JL, Huffnagle GB, Crothers K, Campbell TB, Flores SC, Fontenot AP, Beck JM, Huang L, Lynch S, Knox KS, Weinstock G, Lung HIV Microbiome Project. Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise. Lancet Respir Med. 2013 Jul;1(5):354-6. PubMed PMID: 24429191

Périssé AR, Smeaton L, Chen Y, La Rosa A, Walawander A, Nair A, Grinsztejn B, Santos B, Kanyama C, Hakim J, Nyirenda M, Kumarasamy N, Lalloo UG, Flanigan T, Campbell TB, Hughes MD, P E A R L S study team of the ACTG. Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease. PLoS One. 2013;8(12):e83643. PubMed PMID: 24391801

Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, Buchthal S, Toga AW, Navia B, Thompson PM, HIV Neuroimaging Consortium. Disrupted cerebral metabolite levels and lower nadir CD4 counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage Clin. 2013;3:132-42. PubMed PMID: 24179857

Lozupone CA, Li M, Campbell TB, Flores SC, Linderman D, Gebert MJ, Knight R, Fontenot AP, Palmer BE. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe. 2013 Sep 11;14(3):329-39. PubMed PMID: 24034618

Nelson BC, Borok MZ, Mhlanga TO, Makadzange AT, Campbell TB. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe. Int J Infect Dis. 2013 Oct;17(10):e902-6. PubMed PMID: 23809198

Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, Palmer BE, Wilson CC, MaWhinney S, Kohrt WM, Campbell TB. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis. 2013 Jul 15;208(2):249-59. PubMed PMID: 23559466

Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Bao Y, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, A5185s Team. Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy. Clin Infect Dis. 2013 Jul;57(2):290-7. PubMed PMID: 23532477

Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM, Lung HIV Microbiome Project. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75. PubMed PMID: 23491408

Letang E, Lewis JJ, Bower M, Mosam A, Borok M, Campbell TB, Naniche D, Newsom-Davis T, Shaik F, Fiorillo S, Miro JM, Schellenberg D, Easterbrook PJ. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK. AIDS. 2013 Jun 19;27(10):1603-13. PubMed PMID: 23462220

Erlandson KM, Allshouse AA, Jankowski CM, MaWhinney S, Kohrt WM, Campbell TB. Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):209-15. PubMed PMID: 23392468

Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES, Sodergren E, Mitreva M, Abubucker S, Martin J, Yao G, Campbell TB, Flores SC, Ackerman G, Stombaugh J, Ursell L, Beck JM, Curtis JL, Young VB, Lynch SV, Huang L, Weinstock GM, Knox KS, Twigg H, Morris A, Ghedin E, Bushman FD, Collman RG, Knight R, Fontenot AP, Lung HIV Microbiome Project. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med. 2013 May 15;187(10):1110-7. PubMed PMID: 23392441

Thio CL, Smeaton L, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS. 2013 Jan 14;27(2):191-201. PubMed PMID: 23032418

Thio CL, Smeaton L, Saulynas M, Hwang H, Saravan S, Kulkarn S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS. Characterization of HIV-HBV co-infection in a multi-national HIV-infected cohort. AIDS 2013;27:191-201.

Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, Palmer B, Wilson CC, MaWhinney S, Kohrt WM, Campbell TB. Association of impaired physical function with inflammation and immune activation in HIV-1-infected adults on effective antiretroviral therapy. J Infect Dis (in press)

Erlandson KM, Allshouse AA, Jankowski CM, MaWhinney S, Kohrt WM, Campbell TB. Functional impairment is associated with low bone and muscle mass among persons aging with HIV-infection. J Acquir Immune Defic Syndr 2013 (in press)

Lozupone C, Cota-Gomez A, Palmer BE, Charlson E, Sodergren E, Mitreva M, Abubucker S, Martin J, Yao G, Campbell TB, Flores SC, Ackerman G,Stombaugh J, Ursell L, Beck JM, Curtis JL, Young VB, Lynch SV, Huang L, Weinstock GM, Knox KS, Twigg H, Morris A, Ghedin E, Bushman FD, Collman RG, Knight R, Fontenot AP for the Lung HIV Microbiome Project. Widespread Colonization of the Lung by Tropheryma whipplei in HIV Infection. Am J Resp Critical Care Med. 2013 (in press)

Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Venkataraman A, Schmidt TM, Weinstock G on behalf of the Lung HIV Microbiome Project. Comparison of the respiratory microbiome in healthy non-smokers and smokers. Am J Resp Critical Care Med 2013 (in press)

Letang E, Lewis J, Bower M, Borok M, Mosam A, Campbell T, Naniche D, Macete, Newsom-Davis T, Shaik F, Fiorillo S, Miro JM, Schellenberg D, Easterbrook PJ. Immune Reconstitution Inflammatory Syndrome Associated with Kaposi Sarcoma: Higher Incidence and Mortality in Africa than in the UK. AIDS 2013 (in press)

Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB and the A5185s Team. Higher Genital Tract HIV-1 RNA Before and After Antiretroviral Therapy in Women. Clin Infect Dis 2013 (in press)

Andrade A, Baheti G, Smeaton L, Yang M, Kumarasamy N, Flanigan T, Hakim J, Klingman K, Campbell T, Fletcher C and the ACTG 5175 Team. Efavirenz Pharmacokinetics Are Independently Associated with Virologic Failure in Diverse-Resource Limited Settings. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, 2013.

Balagopal A, Asmuth D, Smeaton L, Gupte N, Franco V, Hakim J, Pollard R, Campbell T, Thomas D, Gupta A, for ACTG5175 and NWCS319 Study Group. Microbial Translocation, Inflammation, and Soluble and Cellular Immune Activation Biomarkers and HAART Outcomes in Resource-limited Settings. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, 2013.

Erlandson K, Allshouse A, Rapaport R, Jankowski C, MaWhinney S, Kohrt W, Wilson C, Campbell T. Impaired Physical Function and Frailty Are Associated with Cytomegalovirus Immunoglobulin G Antibody Concentration in Middle-aged Adults with HIV. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, 2013.

Kantor R, Smeaton L, Vardhanabhuti S, Tripathi S, Morgado M, Saravanan S, Wallis C, Hudelson S, Campbell T, Eshleman S on behalf of A5175 Study Investigators. Baseline HIV Drug Resistance Is Independently Associated with Virologic Failure: Multi-national Prospective Evaluation of ARV in Resource-limited Settings Study, ACTG A5175. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, 2013.

Zheng Y, Hughes M, Lockman S, Hosseinipour M, Campbell T, Salata R, Gulick R, Daar E6, Benson C, Currier J. Efficacy of Different ARV Approaches after Virologic Failure on First-line Ritonavir-boosted Protease Inhibitor Regimens. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, 2013.

Castillo-Mancilla J, Aquilante C, Campbell T, Haas DW, Smeaton L, Wempe MF, Firnhaber C, LaRosa A, Andrade A, Baheti G, Fletcher CV, Anderson PL. Effect of CYP3A5 polymorphisms on the metabolism of atazanavir in HIV-infected patients: a sub-study of AIDS Clinical Trials Group A5175 (NWCS 342). 13th International Workshop on the Clinical Pharmacology of HIV Therapy, Barcelona, 2012.

Castillo-Mancilla J, Allshouse A, Collins C, Hastings-Tolsma, M, Campbell TB, MaWhinney S. Differences in Sexual Risk Behavior and HIV/AIDS Risk Factors among Foreign-born and US-born Hispanic women. J Immigrant Minority Health. 2012;14:89-99.

Castillo-Mancilla J, Campbell TB. Comparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settings. J Comparative Effectiveness Res (in press)

Girard P-M, Campbell T, Grinsztejn B, Hartikainen J,Rachline A,Nijs S, Witek J. Pooled 96-week results of the Phase III DUET-1 and DUET-2 trials of etravirine: analysis of adverse events and laboratory abnormalities of special interest. HIV Med (in press)

Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman K, Shapiro D, Mofenson L, Moran L, Campbell TB, Hitti J, Currier J for the A5190/P1054 Study Team. Assessment of Safety and Toxicity Following Maternal Antiretroviral Exposure in Infants Born To HIV-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World. Eighteen Month Results of AIDS Clinical Trials Group (ACTG) Study 5190/ Pediatric AIDS Clinical Trials Group (PACTG) 1054. Pediatrics (in press)

Erlandson KM, Allshouse A, Duong S, MaWhinney S, Kohrt WM, Campbell TB. HIV, Aging, and Advance Care Planning: Are We Successfully Planning for the Future? J Palliative Med (in press)

Palmer BE, Linderman D, D’Souza M, Li M, Campbell T, Fontenot AP. Differential Expression of Inhibitory Receptors on HIV-1-Specific T Cells in the Lung and Blood of Untreated HIV-1 Infected Subjects. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Firnhaber C, Smeaton L, Grinsztejn B, Chen Y, Lalloo U, Faesen S, Samaneka W, Lama J, Rana A, Campbell T. Sex Association with ARV Efficacy Outcomes in a Prospective Randomized Clinical Trial of ART in Diverse Multinational Settings: The ACTG PEARLS Study. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Balagopal A, Franco V, Smeaton L, Campbell T, Kumarasamy N, Hakim J, Mitsuyasu R, Bollinger R, Thomas D, Gupta A, and ACTG PEARLS and NWCS 319 Study Team. Pre-HAART Initiation Soluble CD14 Levels Vary by Country, Race, and Sex. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Navia B, Gualtieri L, Harezlak J, Daar E, Schifitto G, Taylor M, Campbell T, Letendre S, Cohen R, Yiannoutsos C. Cerebrospinal Fluid Tau, Soluble CD14, and Markers of Neuronal Loss in Chronic HIV Infection. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Navia B, Harezlak J, Daar E, Campbell T, Schifitto G, Singer E, Taylor M, Letendre S, Cohen R, Yiannoutsos C. Predictors of HIV-associated Brain Injury in the Era of cART: The HIV Neuroimaging Consortium Cohort Study. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Wohl D, Arnoczy G, Fichtenbaum C, Campbell T, Taiwo B, Hicks C, McComsey G, Koletar S, Sax P, Stein J. CVD Risk Markers in Patients Receiving Abacavir, Tenofovir, and Zidovudine: The Nucleoside Inflammation, Coagulation, and Endothelial Function (NICE) Study. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Erlandson K, Allshouse A, Jankowski C, MaWhinney S, Kohrt W, Campbell T. Functional Impairment Is Associated with Low Bone and Muscle Mass in Middle-aged HIV-1+ Persons. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012

Havers F, Smeaton L, Detrick B, Campbell T, Bollinger R, Hakim J, Kumarasamy N, Andrade A, Lama J, Gupta A, and the ACTG PEARLS and NWCS 319 Study Team. Vitamin D Insufficiency Is Independently Associated with HIV Disease Progression and Death after cART Initiation in Resource-limited Settings. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012.

Robertson K, Jiang J, Kumwenda J, Supparatpinyo K, Evans S, Campbell T, Price R, Hakim J, Tripathy S, Hosseinipour M, and ACTG 5199 Team. TB-associated Neuropsychological and Neurological Dysfunction in HIV: ACTG A5199, The International Neurological Study. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012.

Fiscus S, Cu-Uvin S, Eshete A, Hughes M, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs R, Campbell T, and A5185s Study Team. Women with HIV-1 Subtype C Have Higher Genital Tract HIV-1 RNA before ART and All Women Are Less Likely to Durably Suppress Genital Tract HIV-1 RNA than Men while on Treatment. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 2012.

Robertson K, Jiang H, Kumwenda J, Supparatpinyo K , Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A and the A5199 study team. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource limited settings: AIDS Clinical Trials Group Study A5199, The International Neurological Study. Clin Infect Dis 2012;55:868-876.

Krishnan S, Schouten JT, Atkinson B, Brown T, Wohl D, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Tebas P, Campbell TB, Jacobson DL. Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naïve HIV-infected individuals. J Acquir Immune Defic Syndr 2012;61:381-389.

Campbell TB, Smeaton L, De Gruttola V, Eshleman SH, Klingman K, Martinez A, Grinsztejn B, Hosseinipour M, Kumwenda J, Lalloo U, Reverie C, Sanchez J, Firnhaber C, Santos BR, Supparatpinyo K, Tripathy T, Moran L, Safren S, Snoden W, Petrella L, Rooney JF, Uy J, Schooley RT, Flanigan T, Kumarasamy N, Hakim J for the PEARLS study team of the ACTG. Efficacy and Safety of Once-Daily Antiretroviral Therapy for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings. PLoS Medicine 2012;9:1-12.

Erlandson KM, Allshouse A, Jankowski C, Duong S, MaWhinney S, Kohrt WM, Campbell TB. A Comparison of Functional Status Instruments in HIV-Infected Adults on Effective Antiretroviral Therapy. HIV Clinical Trials 2012;13:324-34.

Erlandson KM, Allshouse A, Jankowski CM, Duong S, MaWhinney S, Kohrt WM, Campbell TB. Risk factors for recurrent falls in HIV-infected persons. J Acquir Immune Defic Syndr 2012;61:484-9.

Erlandson K, Allshouse A, Duong S, MaWhinney S, Kohrt W, Campbell T. Frailty is associated with psychiatric disease, chronic pain, and poor quality of life in aging HIV-1 infected individuals. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 2011.

Erlandson K, Allshouse A, MaWhinney S, Kohrt W, Campbell T. Frailty in HIV-1 infected individuals is associated with immune activation and inflammation but not immune senescence. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 2011.

Erlandson K, Allshouse A, Duong S, MaWhinney S, Kohrt W, Campbell T. Prevalence and risk factors for frailty in aging HIV-1 infected individuals on suppressive antiretroviral therapy. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 2011.

Andrade A, Baheti G, Smeaton L, Brundage RC, Kumarasamy N, Flanigan T, Hakim J, Braun K, Campbell T, Fletcher CV and the AIDS Clinical Trials Group (ACTG) PEARLS Study. Sex- and geographic-based differences in atazanavir (ATV) pharmacokinetics (PK) in subjects treated with didanosine (ddI-EC), emtricitabine (FTC), and ATV in the AIDS Clinical Trials Group (ACTG) Prospective Evaluation of Antiretrovirals in Resource Limited Settings (PEARLS) Study. 18th Conference on Retroviruses and Opportunistic Infections, Boston, 2011

Robertson K., Jiang H., Kumwenda J., Supparatpinyo K., Evans S., Campbell T., Price R., Tripathy S., Kumarasamy N., LaRosa A. A comparison of neuropsychological and neurological effects of three antiretroviral regimens in diverse resource limited settings: AIDS clinical trials group study A5199, the international neurological study. 18th Conference on Retroviruses and Opportunistic Infections, Boston, 2011.

Cohen R, Harezlak J, Gongvatana A, Schifitto G, Taylor M, Singer E, Campbell T, Daar E, Yiannoutsos C, Navia B, and HIV Neuroimaging Consortium. Conversion to HIV-associated Neurocognitive Disorder. 18th Conference on Retroviruses and Opportunistic Infections, Boston, 2011.

Campbell T, Smeaton L, Kumarasamy N, Flanigan T, Sanchez J, Grinsztejn B, Tripathy S, Kumwenda J, DeGruttola V, Hakim J and the ACTG PEARLS (A5175) Study Team. Efficacy and safety of efavirenz (EFV) with either co-formulated lamivudine/zidovudine (3TC/ZDV) or emtricitabine/tenofovir-DF (FTC/TDF) for initial treatment of HIV-1 infected men and women in diverse multinational settings. 18th Conference on Retroviruses and Opportunistic Infections, Boston, 2011.

Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B. HIV Neuroimaging Consortium. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 2011 13;25:625-33.

Tate DF, Sampat M, Fiecas M, Hogan J, Harezlak J, Russell T, Conley J, Price J, McCaffrey D, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Siqueiros L, Paulose, S, Gaugh M, Tripolica C, Janetta Gotts, Paul RH, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CRG, Navia B for the HIV MRS Consortium. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neuro Virol 2011;17:368-79.

Safren S, Celentano D, Smeaton L, Hendriksen E, Hosseinipour M, Barnett R, Guanira J, Flanigan T, Kumarasamy N, Klingman K, Swann E, De Gruttola V, Campbell T for the PEARLS Study Team. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS and Behavior 2011 Apr 16. [Epub ahead of print].

Grinsztejn B, Smeaton L, De Gruttola V, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J and the PEARLS study team of the ACTG. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4 cell count. Antivir Ther. 2011;16:1057-1062.

Nahid P, Saukkonen J, Mac Kenzie W, Johnson JL, Phillips P, Bliven E, Andersen J, Belisle J, Boom H, Campbell T, Eisenach K, Hafner R, Lennox J, Leutkemeyer a, Livnat D, Makhene M, Swindells S, Villarino EM, Weiner M, Benson C, Burman W. Tuberculosis biomarker and surrogate endpoint research roadmap: Summary of Joint CDC/NIH Tuberculosis Biomarkers Workshop. Am J Resp Critical Care Med. 2011; 184:972-9.

Robertson K, Kumwenda J, Supparatpinyo K, Evans S, Jiang H, Campbell TB, Price RW, Murphy R, Hall C, Marra C, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P, and the AIDS Clinical Trials Group. A multinational study of neurocognitive performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neuro Virol 2011;17:438–447.

Meditz AL, Haas MK, Folkvord JM, Melander K, Young R, McCarter M, MaWhinney S, Campbell TB, Weinberg A, Lie Y, Coakley E, Levy DN, Connick E. HLA-DR+CD38+CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. J Virol 2011;85:10189–10200.

Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Brown M, Singer E, Campbell T, Mcmahan D, Tso Y, Matesan J, Ernst T, Yiannoutsos C, Cohen R, Navia BA and the HIV Neuroimaging Consortium. Persistence of HIV-associated cognitive impairment, inflammation and neuronal injury in the HAART era. AIDS (in press).

Tate DF, Sampat M, Fiecas M, Hogan J, Harezlak J, Russell T, Conley J, Price J, McCaffrey D, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Siqueiros L, Paulose, S, Gaugh M, Tripolica C, Janetta Gotts, Paul RH, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CRG, Navia B for the HIV MRS Consortium. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neuro Virol (in press).

Safren S, Celentano D, Smeaton L, Hendriksen E, Hosseinipour M, Barnett R, Guanira J, Flanigan T, Kumarasamy N, Klingman K, Swann E, De Gruttola V, Campbell T for the PEARLS Study Team. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS and Behavior (in press).

Grinsztejn B, Smeaton L, De Gruttola V, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J and the PEARLS study team of the ACTG. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4 cell count. Antiviral Therapy (in press).

Nelson BC, Borok MB, Makadzange T, Mhlanga T, Campbell TB. AIDS-related Kaposi’s sarcoma: Outcomes after initiation of highly active antiretroviral therapy under routine conditions in Zimbabwe. The 12th International Conference on Malignancy in AIDS and Other Acquired Immunodeficiencies, Bethesda, MD, 2010.

Borok MZ, Fiorillo S, Gudza I, Ndemera B, Putnam B, Watson H, Wegzyn C, Gwanzura L, Campbell T. A pilot study of co-formulated abacavir/lamivudine/zidovudine versus coformulated abacavir/lamivudine plus co-formulated lopinavir/ritonavir for treatment of refractory AIDS-KS in an African setting. XVIII International AIDS Conference, Vienna, 2010.

Castillo-Mancilla J, Allshouse A, Collins C, Hastings-Tolsma M, Campbell T, MaWhinney S. Differences in sexual risk behavior and HIV/AIDS risk factors among foreign born and US-born Hispanic women in the United States. XVIII International AIDS Conference, Vienna, 2010.

Andrade A, Rosenkranz S, Daar E, Jacobson J, Acosta E5, Lederman M, Town J, Campbell T, Mellors J, Kuritzkes D for the ACTG 5248 team. Longer phase I viral decay in treatment-naïve patients receiving raltegravir-based ART: Preliminary results from ACTG 5248. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2010.

Thio C, Smeaton L, Saulynas M, Hwang H, Kumarasamy N, Flanigan T, Hakim J, Amod F, Campbell T, Currier J and the PEARLS/A5175 and OCTANE/A5208 Study Teams for the ACTG. Characterization of hepatitis B virus (HBV) and its association with HIV in an antiretroviral therapy (ART)-naïve, multi-national cohort from 2 randomized controlled trials (RCT) of the AIDS Clinical Trials Group (ACTG). 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2010.

Letang E, Almeida J, Ayala E, Miró JM, White IE, Carrilho C, Bastos R, Nhampossa T, Gascón J, Menéndez C, Campbell TB, Alonso P, Naniche D. Predictors of immune reconstitution inflammatory syndrome associated with Kaposi sarcoma (IRIS-KS) in a rural area of Mozambique. JAIDS 2010;53:589-597.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Algers J, Brown M, Zhong J, Campbell T, Singer E, McMahon D, Tso Y, Yiannoutsos CT, Navia B and the HIV Neuroimaging Consortium. Effects of nadir CD4 count and duration of HIV infection on brain volumes in the highly active antiretroviral therapy era. J Neuro Virol 2010;16:1–8.

Borok M, Fiorillo S, Gudza I, Putnam B, Ndemera B, White IE, Watson H, Gwanzura L, Schooley RT, Campbell TB. Evaluation of plasma human Herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy of AIDS-related Kaposi’s sarcoma in Zimbabwe. Clin Infect Dis. 2010;51:342–349.

Firnhaber C, Smeaton L, Saukila N, Flanigan T, Gangakhedkar R, Kumwenda J, La Rosa A, Kumarasamy N, De Gruttola V, Hakim JG, Campbell TB. Comparisons of anemia, thrombocytopenia and neutropenia at initiation of antiretroviral therapy in Africa, Asia and the Americas. Int J Infect Dis. 2010;14:e1088–1092.

Letang E, Almeida J, Ayala E, Miró JM, White IE, Carrilho C, Bastos R, Nhampossa T, Gascón J, Menéndez C, Campbell TB, Alonso P, Naniche D. Predictors of immune reconstitution inflammatory syndrome associated with Kaposi sarcoma (IRIS-KS) in a rural area of Mozambique. JAIDS 2010;53:589-597.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Algers J, Brown M, Zhong J, Campbell T, Singer E, McMahon D, Tso Y, Yiannoutsos CT, Navia B and the HIV Neuroimaging Consortium. Effects of nadir CD4 count and duration of HIV infection on brain volumes in the highly active antiretroviral therapy era. J Neuro Virol 2010;16:1–8.

Campbell TB, Borok M, Ndemera B, Fiorillo S, White IE, Zhang XQ, Machekano R, Katzenstein D, Gwanzura L. Lack of Evidence for Frequent Heterosexual Transmission of Human Herpesvirus 8 (HHV-8) in Zimbabwe. Clin Infect Dis 2009;48:1601-8.

Campbell TB, Borok M, Ndemera B, Fiorillo S, White IE, Zhang XQ, Machekano R, Katzenstein D, Gwanzura L. Lack of Evidence for Frequent Heterosexual Transmission of Human Herpesvirus 8 (HHV-8) in Zimbabwe. Clin Infect Dis 2009;48:(in press)

Navia B, Harezlak J, Buchthal S, Cohen R, Taylor M, Schifitto G, Singer E, Campbell T, Daar E, Yiannoutsos C and the HIV Neuroimaging Consortium. Persistence of HIV-related Brain Injury in the HAART Era: A Multicenter Proton Magnetic Resonance Spectroscopy Study. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, 2009.

Robertson K, Jiang H, Tripathy S, Santos B, Silva M, Montano S, Kanyama C, Firnhaber C, Evans S, Campbell T, and the ACTG 5199 Team. Improved Neuropsychological Function during HAART in Diverse Resource-limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, 2009.

Gwanzura L, Samaneka L, Samaneka W, Mudzviti1 E, Mutimuri M, Taziwa A, Ndemera B, Tinago W, Mandozana G, Hakim J, Borok M, Campbell T, Barron M, Connick E. Identification and presentation of primary HIV-1 infection in Harare, Zimbabwe. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, 2009.

Campbell T, Grinsztejn B, Hartikainen J, Nijs S, Witek J. Long-term safety profile of etravirine in treatment-experienced, HIV-1-infected patients: pooled 96-week results from the phase III DUET trials. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, 2009.

Johnson M, Campbell T, Clotet B, Katlama C, Lazzarin A, Towner W, Peeters M, Vingerhoets J, Bollen S, De Smedt G on behalf of the DUET-2 study group. DUET-2:Week 48 results of a Phase III randomized double-blind trial to evaluate the efficacy and safety of etravirine (ETR; TMC125) versus placebo in 591 treatment-experienced HIV-1-infected patients. 15th Conference on Retroviruses and Opportunistic Infections, Boston, 2008.

Robertson K, Kumwenda J, Supparatpinyo K, Evans S, Jiang H, Campbell T and the 5199 study team. Baseline Data from ACTG 5199: The International Neurological Study. 15th Conference on Retroviruses and Opportunistic Infections, Boston, 2008.

Grinsztejn B, Smeaton L, De Gruttola V, Barnett R, Currier J, Swann E, Hakim J, Flanigan T, Kumarasamy N, Campbell T for the PEARLS Study Team of the ACTG. Gender-associated Differences in Pre-Antiretroviral Therapy Plasma HIV-1 RNA in Diverse Areas of the World Depend on CD4+ Lymphocyte Count. 15th Conference on Retroviruses and Opportunistic Infections, Boston, 2008.

White T, Hagen M, Gudza I, White IE, Ndemera B, Gwanzura L, Borok M, Campbell TB. Genetic diversity of the Kaposi’s sarcoma herpesvirus K1 protein in Zimbabwe. J Clin Virol Journal of Clinical Virology 2008;42:165–171.

Bull TM, Meadows CA, Coldren C, Moore M, Nana-Sinkam SP, Campbell TB, Geraci MW. Human herpesvirus 8 infection of primary pulmonary microvascular endothelial cells. Am J Resp Cell Molec Biol 2008;39:706-16.

Campbell TB. Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virological failure. Clin Infect Dis 2008;43:723-725.

Andrade A, Smeaton L, Campbell T, Bollinger R, Mitsuyasu R, Lama J, Klingman K, Hakim J, Kumarasamy N, Gupta A, for the PEARLS study team of the ACTG. Baseline correlates of pre-antiretrovial therapy nutritional status among HIV-infected adults in diverse regions of the world. XVII International AIDS Conference Mexico City, 2008.

Katlama K, Campbell T, Schechter M, Peeters M, Bicer C, Sinha R, Leopold L, De Smedt G. Incidence and severity of nervous system and psychiatric events are similar with etravirine (ETR, TMC125) versus placebo: pooled 48-week data from the phase III DUET studies. XVII International AIDS Conference Mexico City, 2008.

Firnhaber C, Smeaton L, Hakim J, De Gruttola V, Swann E, Flannigan T, Kumarasamy N, Campbell T, for the PEARLS Study Team of the ACTG. The strength of the correlation between total lymphocyte count and CD4+ lymphocyte count varies in diverse areas of the world. XVII International AIDS Conference Mexico City, 2008.

Gwanzura L, Samaneka L, Mudzviti E, Mutimuri M, Mugutso A, Ndemera B, Taziwa A, Mandozana G, Tinago W, Samaneka W, Hakim J, Borok M, Campbell T, Connick E. Identification and presentation of primary HIV-1 infection in Zimbabwe. XVII International AIDS Conference Mexico City, 2008.

Borok M, Gudza I, Fiorillo S, Ndemera B, Fernandez G, Putnam B, Loeschel E, Gwanzura L, Schooley R, Campbell T. A pilot study of the effects of highly active antiretroviral therapy on Kaposi’s sarcoma in Zimbabwe. XVII International AIDS Conference Mexico City, 2008.

Safren S, Celentano D, Smeaton L, Hendriksen E, Hosseinipour M, Barnett R, Guanira J, Flanigan T, Kumarasamy N, Klingman K, Swann E, De Gruttola V, Campbell T for the PEARLS Study Team. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. XVII International AIDS Conference Mexico City, 2008.

Campbell T, Smeaton L, De Gruttola V, Hakim J, Kumarasamy N, Flanigan T, Klingman K, Martinez A, Berendes S, Cardoso S, Firnhaber C, Hosseinipour M, Joglekar A, Mngqibisa R, Rivière C, Sanchez J, Santos B, Supparatpinyo K, Nair A, Walawander A, Hosey L, Moran L, Barnett R, Swann E, Loeschel E, Pakes G, Piliero P, Rooney J, Snowden W, Thal G, Uy J, Andrade A, Currier J, Eron J, Eshleman S, Fiscus S, Gulick R, Haas D, Hammer S, Mitsuyasu R, and Schooley R, for the PEARLS study team of the ACTG. PEARLS (ACTG A175): A multinational study of didanosine-EC, emtricitabine and atazanavir vs. co-formulated zidovudine/lamivudine and efavirenz for initial treatment of HIV-1 infection. XVII International AIDS Conference Mexico City, 2008.

Campbell T, Peeters M, Nijs S, Kakuda T, Witek J, De Smedt G. Safety and tolerability of etravirine, a newly approved NNRTI for the management of treatment-experienced patients with HIV, in patients co-infected with hepatitis B or C virus. National Conference on Correctional Health Care, Chicago, 2008.

Paredes R, Marconi VC, Campbell TB, Kuritzkes DR. Systematic evaluation of allele-specific real time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations. J Virol Meth (in press).

White T, Hagen M, Gudza I, White IE, Ndemera B, Gwanzura L, Borok M, Campbell TB. Genetic diversity of the Kaposi’s sarcoma herpesvirus K1 protein in Zimbabwe. J Clin Virol (in press).

Borok M, Gudza I, Fiorillo S, Ndemera B, Putnam B, Loeliger E, Gwanzura L, Schooley R, Campbell T. A 48 week efficacy and safety analysis of treatment of AIDS-KS with co-formulated ABC/3TC/ZDV in Zimbabwe. African International Conference on Immunity, Victoria Falls, 2007.

Gwanzura L, Ndemera B, Fiorillo SP, White IE, Zhang XQ, Machekano R, Katzenstein D, Borok M, Campbell TB. Seroprevalence and risk factors for HHV-8 Infection in Zimbabwe. African International Conference on Immunity, Victoria Falls, 2007.

Katlama C, Campbell T, Clotet B, Johnson M, Lazzarin A, Towner W, Trottier B, Peeters M, Vingerhoets J, De Smedt G, Baeten B, Beets G, Sinha R, Woodfall B on behalf of the DUET-2 study group. DUET-2: 24 week results of a randomised double-blind trial to evaluate the efficacy and safety of TMC125 versus placebo in 591 treatment-experienced HIV-1 infected patients. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, 2007

Campbell T, Mills A, Morlat P, Schechter M, De Smedt G, Peeters M, Tomaka F, Woodfall B. TMC125 safety and tolerability in treatment-experienced hepatitis B or C co-infected patients in DUET-1 and DUET-2. HepDART, Maui, 2007

Gripshover B, Santana J, Ribaudo H, Gerber J, Campbell TB, Hogg E, Jarocki B, Hammer S, and Kuritzkes D. A randomized, placebo-controlled trial of amdoxovir vs placebo with enfuvirtide plus optimized background therapy for HIV-infected subjects failing current therapy (AACTG 5118). Antiviral Therapy (in press)

Meditz AL, Borok M, Gudza I, Ndemera B, Gwanzura L, Campbell TB. Sex Differences in AIDS-associated Kaposi’s Sarcoma in Zimbabwe. J Acquir Immune Def Syndr (in press).

Boritz E, Rapaport E, Campbell TB, Koeppe JR, Wilson CC. CD4+ T Cell Targeting of HIV-1 peptide sequences present in vivo during chronic, progressive HIV-1 disease. Virology (in press)

Meditz AL, Borok M, Gudza I, Ndemera B, Gwanzura L, Campbell TB. Gender Differences in AIDS-associated Kaposi’s Sarcoma in Harare, Zimbabwe. J Acquir Immune Defic Syndr 2007;44:306–308.

Boritz E, Rapaport E, Campbell TB, Koeppe JR, Wilson CC. CD4+ T Cell Targeting of HIV-1 peptide sequences present in vivo during chronic, progressive HIV-1 disease. Virology 2007;361:34-44.

Lazzarin A, Campbell T, Clotet B, Johnson M, Katlama C, Moll A, Towner W, Trottier B, Peeters M, Vingerhoets J, De Smedt G, Baeten B, Beets G, Sinha R, Woodfall B on behalf of the DUET-2 study group. DUET-2: 24 week results of a randomised double-blind trial to evaluate the efficacy and safety of TMC125 versus placebo in 591 treatment-experienced HIV-1 infected patients. Lancet 2007;370:39-48.

Boritz E, Rapaport E, Campbell T, Koeppe J, Wilson C. CD4+ T-cell targeting of HIV-1 peptide sequences present in vivo during chronic, progressive HIV-1 disease. 13th Conference on Retroviruses and Opportunistice Infections, Denver, 2006

White T, Hagen M, Gudza I, Ndemera B, White I, Borok M, Campbell T. Genetic diversity of Kaposi’s sarcoma herpesvirus in Zimbabwe. 13th Conference on Retroviruses and Opportunistice Infections, Denver, 2006.

Borok M, Ndemera B, Gudza I, Gwanzura L, Campbell T. Kaposi’s sarcoma-associated herpesvirus infection is uncommon among Zimbabwean blood donors. 13th Conference on Retroviruses and Opportunistice Infections, Denver, 2006.

Meditz A, Borok M, Gudza I, Gwanzura L, Ndemera B, Campbell T. Is there sex discrimination in AIDS-associated Kaposi’s sarcoma? 13th Conference on Retroviruses and Opportunistice Infections, Denver, 2006

Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kellecher AD, Kaldor J, Routh JP, Campbell TB, Rosenberg E, Schafer K, Wood K, Weidler J, Bates M, Grant RM. Greater CD4+ T cell responses during antiretroviral therapy associates with lower viral pol replication capacity. AIDS 2006;20:2123-2125.

Koeppe JR, Campbell TB, Rapaport EL, Wilson CC. HIV-1 specific CD4+ T cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. J Acquir Immune Defic Syndr. 2006;41:140-148

Campbell TB, Staskus KA, Folkvord J, White IE, Neid J, Zhang X-Q, Connick E. Persistence of Kaposi’s sarcoma-associated herpesvirus (KSHV) infected cells in HIV-1 co-infected persons without KSHV-associated diseases. J Infect Dis 2005; 191:367-371.

Flanigan TP, Campbell T, Harwell J, and Kumarasamy N. The extraordinary hope of antiretroviral therapy in South Africa (Even for patients with tuberculosis or Kaposi sarcoma!). J Infect Dis 2005;191:321-323.

Campbell TB, Katzenstein D. Antiretroviral Rounds. Resistance: How do you know if you don't know?. Antiretroviral Rounds. AIDS Clin Care 2005;17.

Connick E, MaWhinney S, Wilson CC, Campbell TB. Challenges in the study of HIV-1 seroconverters. Clin Infect Dis 2005;40:1355-1357.

Campbell TB, Shulman N, Johnson SC, Zolopa AR, Young RK, Bushman L, Fletcher CV, Lanier ER, Merigan T, Kuritzkes DR. Antiviral activity of lamivudine in salvage therapy of multidrug-resistant human immunodeficiency virus type 1 infection. Clin Infect Dis 2005;41:236-242.

Campbell TB. Are all HIV-1 created equal? Clin Infect Dis 2006;42:853-854.

Barbour JD, Hecht FM, Markowitz M, Little SJ, Daar ES, Kelleher A, Routy JP, Campbell T, Rosenberg E, Schafer K, Wood K, Segal M, Weidler J, Bates M, Grant RM. Greater CD4+ T Cell Rate of Gain During Anti-Retroviral Therapy Is Associated with Lower Pre-Treatment Viral pol Replication Capacity Independent of Virologic Response. The 3rd IAS Conference on HIV Pathogenesis and Treatment, 2005. Abstract WePe8.4B04

Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kellecher AD, Kaldor J, Routh JP, Campbell TB, Rosenberg E, Schafer K, Wood K, Weidler J, Bates M, Grant RM. Greater CD4+ T cell responses during antiretroviral therapy associates with lower viral pol replication capacity.

Gripshover B, Santana J, Ribaudo H, Gerber J, Campbell T, Hogg E, Jarocki B, Hammer S, and Kuritzkes D. A randomized, placebo-controlled trial of amdoxovir vs placebo with enfuvirtide plus optimized background therapy for HIV-infected subjects failing current therapy (AACTG 5118). .

Professor, Medicine-Infectious Disease

Medical School

Graduate School

Undergraduate School

Internship

Residency

Fellowships

Languages

Department

Research Interests

Publications

Professional Memberships

Practice Locations

Specialty Information

School of Medicine

CU Anschutz

Fitzsimons Building